Edgar Lomax Company’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.3M | Sell |
157,570
-14,175
| -8% | -$1.14M | 0.92% | 44 |
|
|
2026
Q1 | $14.9M | Sell |
171,745
-83,355
| -33% | -$7.99M | 1.06% | 41 |
|
|
2025
Q4 | $24.5M | Sell |
255,100
-5,830
| -2% | -$566K | 1.86% | 19 |
|
|
2025
Q3 | $24.9M | Sell |
260,930
-76,155
| -23% | -$7M | 1.95% | 19 |
|
|
2025
Q2 | $29.4M | Sell |
337,085
-5,400
| -2% | -$458K | 1.86% | 20 |
|
|
2025
Q1 | $30.8M | Buy |
342,485
+24,905
| +8% | +$2.23M | 1.92% | 20 |
|
|
2024
Q4 | $25.4M | Sell |
317,580
-6,080
| -2% | -$526K | 1.64% | 26 |
|
|
2024
Q3 | $29.1M | Sell |
323,660
-5,115
| -2% | -$430K | 1.78% | 23 |
|
|
2024
Q2 | $25.9M | Sell |
328,775
-5,835
| -2% | -$478K | 1.68% | 25 |
|
|
2024
Q1 | $29.2M | Sell |
334,610
-3,188
| -0.9% | -$272K | 1.8% | 22 |
|
|
2023
Q4 | $27.8M | Sell |
337,798
-13,700
| -4% | -$1.04M | 1.82% | 24 |
|
|
2023
Q3 | $27.5M | Sell |
351,498
-5,845
| -2% | -$489K | 1.88% | 25 |
|
|
2023
Q2 | $31.5M | Sell |
357,343
-4,832
| -1% | -$416K | 2.07% | 23 |
|
|
2023
Q1 | $29.2M | Buy |
362,175
+172,105
| +91% | +$14M | 1.88% | 24 |
|
|
2022
Q4 | $14.8M | Sell |
190,070
-1,880
| -1% | -$152K | 0.9% | 39 |
|
|
2022
Q3 | $15.5M | Sell |
191,950
-2,155
| -1% | -$194K | 1.07% | 36 |
|
|
2022
Q2 | $17.4M | Buy |
194,105
+5,255
| +3% | +$532K | 1.09% | 31 |
|
|
2022
Q1 | $21M | Buy |
+188,850
| New | +$20M | 1.23% | 31 |
|
|
2019
Q1 | – | Sell |
-175,275
| Closed | -$15.9M | – | 73 |
|
|
2018
Q4 | $15.9M | Sell |
175,275
-3,100
| -2% | -$290K | 1.21% | 26 |
|
|
2018
Q3 | $17.5M | Sell |
178,375
-6,200
| -3% | -$573K | 1.18% | 29 |
|
|
2018
Q2 | $15.8M | Buy |
184,575
+1,500
| +0.8% | +$125K | 1.11% | 30 |
|
|
2018
Q1 | $14.7M | Buy |
+183,075
| New | +$15.1M | 1.06% | 33 |
|
|
2015
Q1 | – | Sell |
-26,300
| Closed | -$1.9M | – | 66 |
|
|
2014
Q4 | $1.9M | Sell |
26,300
-606,159
| -96% | -$42.1M | 0.12% | 56 |
|
|
2014
Q3 | $39.2M | Buy |
632,459
+15,760
| +3% | +$1M | 2.66% | 17 |
|
|
2014
Q2 | $39.3M | Buy |
616,699
+1,075
| +0.2% | +$65.3K | 2.78% | 16 |
|
|
2014
Q1 | $37.9M | Buy |
615,624
+54,950
| +10% | +$3.2M | 2.79% | 15 |
|
|
2013
Q4 | $32.2M | Buy |
560,674
+272,700
| +95% | +$15.5M | 2.43% | 16 |
|
|
2013
Q3 | $15.3M | Sell |
287,974
-25,800
| -8% | -$1.39M | 1.26% | 35 |
|
|
2013
Q2 | $16.1M | Buy |
+313,774
| New | +$15.5M | 1.26% | 33 |
|
Other funds holding MDT
Edgar Lomax Company's MDT Position: Q2 2026 in Review
Edgar Lomax Company reduced its Medtronic (MDT) stake by 8.3% in Q2 2026, selling an estimated $1.14M and leaving 157,570 shares worth $12.3M. The position accounts for 0.92% of the portfolio, ranked #44.
Edgar Lomax Company first reported a position in MDT in Q2 2013 and has held it in 29 quarters since. The position peaked at $39.3M in Q2 2014. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Edgar Lomax Company held 157,570 shares of Medtronic worth $12.3M as of Q2 2026.
- Edgar Lomax Company sold 14,175 Medtronic shares in Q2 2026, an estimated $1.14M.
- Medtronic made up 0.92% of Edgar Lomax Company's portfolio in Q2 2026, its #44 holding.
- Edgar Lomax Company first reported a position in Medtronic in Q2 2013 and has held it in 29 quarters since.
- Edgar Lomax Company's Medtronic position peaked at $39.3M in Q2 2014.
- 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Edgar Lomax Company's 13F filing for Q2 2026, filed 13 Aug 2026.